000 04080cam a2200577Ii 4500
001 on1023028364
003 OCoLC
005 20180529120024.0
008 180214s2018 enka ob 001 0 eng d
019 _a1023487537
020 _a9780128096949
_q(electronic bk.)
020 _a0128096942
_q(electronic bk.)
020 _z9780128094549
020 _z0128094540
035 _a(OCoLC)1023028364
040 _aDLC
_beng
_cDLC
_dAU
049 _aAlfaisal Main Library
050 4 _aRC662.18
_b.T966 2018
245 0 0 _aType 2 diabetes and dementia /
_cedited by Velandai Srikanth, Zoe Arvanitakis.
264 1 _aLondon, United Kingdom :
_bAcademic Press,
_c[2018]
300 _a1 online resource (305 pages) :
_billustrations (some in color)
336 _atext
_btxt
_2rdacontent
336 _astill image
_bsti
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
504 _aIncludes bibliographical references and indexes.
520 _aType 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment and prevention strategies, and the application of therapeutics. The book reflects the translational aspects of the current science in the field, with an emphasis on the display of neuroimaging and neuropathology. It contains contributions from world experts, and is ideal for clinicians and researchers in the fields of neurology, neuroscience, geriatric medicine and endocrinology. Presents a comprehensive overview that details the relationship between diabetes, dementia and the future of medicine and therapeutics Written for researchers and clinicians in neurology, neuroscience, geriatric medicine and endocrinologyIncludes topics ranging from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment, prevention strategies and therapeutic applications
588 0 _aVendor-supplied metadata.
505 0 _a1. Introduction -- 2. Epidemiology of type 2 diabetes and dementia -- 3. Magnitude and trajectories of Type 2 diabetes mellitus (DM)-associated cognitive dysfunction -- 4. Brain Imaging in Diabetes -- 5. Cerebrospinal fluid and blood-based biomarkers in Alzheimer’s disease and type 2 diabetes spectrum disorders -- 6. Neuropathologic insights into diabetes -- 7. Diet, obesity, exercise, metabolism and brain -- 8. The role of insulin resistance and signalling in dementia -- 9. Advanced glycation, diabetes and dementia -- 10. Neuroinflammation, type 2 diabetes and dementia -- 11. The blood-brain barrier in diabetes mellitus -- 12. Pharmacological and non-pharmacological interventions for cognitive impairment and dementia related to type 2 diabetes and metabolic disturbances in aging
590 _aElsevier
_bScienceDirect All Books
650 0 _aNon-insulin-dependent diabetes.
650 0 _aDementia.
650 0 _aNon-insulin-dependent diabetes
_xPrevention.
650 7 _aHEALTH & FITNESS / Diseases / General.
_2bisacsh
650 7 _aMEDICAL / Clinical Medicine.
_2bisacsh
650 7 _aMEDICAL / Diseases.
_2bisacsh
650 7 _aMEDICAL / Evidence-Based Medicine.
_2bisacsh
650 7 _aMEDICAL / Internal Medicine.
_2bisacsh
650 7 _aDementia.
_2fast
_0(OCoLC)fst00890050
650 7 _aNon-insulin-dependent diabetes.
_2fast
_0(OCoLC)fst01038549
650 7 _aNon-insulin-dependent diabetes
_xPrevention.
_2fast
_0(OCoLC)fst01038556
650 1 2 _aDiabetes Mellitus, Type 2
_xcomplications.
650 2 2 _aDementia.
655 7 _aElectronic books.
_2local
700 1 _aSrikanth, Velandai,
_eeditor.
700 1 _aArvanitakis, Zoe,
_eeditor.
710 2 _aScienceDirect eBooks.
776 0 8 _cOriginal
_z9780128094549
_z0128094540
_w(OCoLC)1001456673
856 4 0 _uhttp://ezproxy.alfaisal.edu/login?url=https://www.sciencedirect.com/science/book/9780128094549
942 _2lcc
_cEBOOKS
260 _c[2018]
999 _c543058
_d543058